Resistência Antifúngica

Cápsula de vídeo informativo sobre o surgimento de infecções com resistência antifúngica.

PP-PFE-BRA-2775  
 

Referências:
- CDC. Antibiotic Resistance Threats in the United States, 2019. Atlanta, GA: EUA Ministério da Saúde e Serviços Humanos, CDC; 2019.
- Wiederhold NP. Antifungal resistance: current trends and future strategies to combat. Infect Drug Resist. 2017;10:249-259. 
- Friedman DZP, Schwartz IS. Emerging Fungal Infections: New Patients, New Patterns, and New Pathogens. J Fungi (Basel). 2019;5(3). pii: E67.
- Ksiezopolska E, Gabaldón T. Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens. Genes (Basel). 2018;9(9). pii: E461. 
- Gong J, Xiao M, Wang H, et al. Genetic Differentiation, Diversity, and Drug Susceptibility of Candida krusei.  Front Microbiol. 2018;9:2717.
- Pfaller MA, Diekema DJ, Turnidge JD, et al. Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997-2016. Open Forum Infect Dis. 2019;6(Suppl 1):S79-S94. 
- Wiederhold NP. Antifungal resistance: current trends and future strategies to combat. Infect Drug Resist. 2017;10:249-259. 
- Natesan SK. Evolution of Candida Diagnostics: Are We There Yet? J Mycol Mycological Sci 2019, 2(1): 000104.
- Titmarsh S. Tackling the growing problem of antifungal resistance. UK Prescriber. 2018;29:24-27.
- von Lilienfeld-Toal M, Wagener J, Einsele H, et al. Invasive fungal infection—new treatments to meet new challenges. Dtsch Arztebl Int. 2019; 116: 271–278.
- Hamdy RF, Zaoutis TE, Seo SK. Antifungal stewardship considerations for adults and pediatrics. Virulence. 2017;8(6):658–672.